Pancreatic cancer (PC) is a devastating disease, offering poor mortality rates for patients.
The current challenge being faced is the inability to diagnose patients in a timely manner …

Simple Summary Even today, pancreatic cancer still has a dismal prognosis. It is
characterized by a lack of early symptoms and thus late diagnosis as well as early …

Pancreatic ductal adenocarcinoma (PDAC) is an extremely deadly form of cancer, with
limited progress in 5-year survival rates despite significant research efforts. The main …

Extracellular vesicles (EVs) like exosomes and shed microvesicles are generated by many
different cells. However, among all the cells, cancer cells are now recognized to secrete …

Pancreatic cancer is one of the most aggressive tumors, with a dismal prognosis due to poor
detection rates at early stages, rapid progression, post-surgical complications, and limited …

Pancreatic cancer is the fourth most common cause of death due to cancer in the world. It is
known to have a poor prognosis, mostly because early stages of the disease are generally …

Pancreatic cancer (PC) incidence is rising and due to late diagnosis, combined with
unsatisfactory response to current therapeutic approaches, this tumor has an extremely high …

Pancreatic cancer is one of the most lethal cancers worldwide due to its insidious symptoms,
early metastasis, and chemoresistance. Hence, the underlying mechanisms contributing to …

Background Pancreatic cancer (PC) remains one of the most fatal forms of cancer worldwide
with incidence nearly equal to mortality. This is often attributed to the fact that diagnosis is …

Pancreatic Ductal Adenocarcinoma (PDAC) constitutes a leading cause of cancer death
globally. Its mortality remains unaltered despite the considerable scientific progress made in …